Abstract
Anti-mullerian hormone (AMH), a peptide secreted by pre- and early antral follicles, is a promising biomarker of oocyte aging, since it predicts response to outcome after IVF, but little is know about what ovarian factors determine AMH levels in women. Are AMH levels determined by ovarian reserve, i.e. number of follicles, or by their “quality”?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
